SCHEMBL5800901

SCHEMBL5800901

FC(F)(F)c1ccc(-n2ccc3[c]cccc32)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
KCNH2 Q12809 1/20 0.34
BIRC5 O15392 1/20 0.33
ALDH1A1 P00352 1/20 0.32
TSHR P16473 1/20 0.32
DRD4 P21917 1/20 0.32
GRM2 Q14416 1/20 0.32
CYP19A1 P11511 1/20 0.32
TRPV1 Q8NER1 1/20 0.32
CASR P41180 1/20 0.32
MPI P34949 1/20 0.31
PHOSPHO1 Q8TCT1 1/20 0.31
MGLL Q99685 1/20 0.31
SCN9A Q15858 1/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
ALOX15B O15296 1/20 0.31
NOTUM Q6P988 1/20 0.31
MAPT P10636 1/20 0.30
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL694088 0.83 KCNH2 (0.39) KCNH2BIRC5ALDH1A1TSHRCYP19A1
SCHEMBL408242 0.81 BIRC5 (0.38) BIRC5L3MBTL1NOTUM
SCHEMBL5591817 0.76 GSK3A (0.38) CYP19A1TRPV1MPIPHOSPHO1SCN9A
SCHEMBL28220764 0.73 BIRC5 (0.62) KIF11TDP1KCNH2BIRC5ALDH1A1
SCHEMBL145051 0.68 KCNH2 (0.43) TDP1KCNH2BIRC5CYP19A1MGLL
SCHEMBL16462295 0.68 TRPV1 (0.48) KIF11BIRC5ALDH1A1TRPV1MPI
SCHEMBL1450364 0.64 NQO2 (0.47) ALDH1A1MAPT
SCHEMBL10971445 0.64
SCHEMBL5543369 0.63 ALDH1A1 (0.38) KIF11TDP1ALDH1A1TSHRTRPV1
SCHEMBL2541502 0.63 BACE1 (0.37) KIF11ALDH1A1TSHRMGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1670794-A2 VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS Amgen Inc. (US) 2006-06-21 EP disclosed
WO-2005033105-A2 VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS AMGEN INC. (US) 2005-04-14 WO disclosed